Spinal cord stimulation uses electrical impulses to relieve chronic pain in the back and legs. Patients with burning, numbness, and shooting pain in the legs may benefit the most from a spinal cord stimulator. The stimulator applies electrical impulses to the spinal cord to block pain signals from reaching the brain. The device consists of an electrical pulse generator, a battery, and electrical leads that are positioned within the epidural space to stimulate the spinal cord. Implantation of the device is a two step process. An external trial stimulator is used for seven days after the epidural leads are placed. If there is pain relief for seven days, then the patient is a candidate for a permanent spinal cord stimulator.

It is believed that applying electrical impulses to certain areas of the spinal cord can prevent pain signals from reaching the brain. The brain is almost “tricked” by feeling the stimulation signals, and ignoring the pain signals.
Under X-ray (fluoroscopic) guidance, a needle is directed into the epidural space, just below the end of the spinal cord. Electrical leads are passed into the epidural space to lie over the spinal cord. Electrical impulses are sent through the leads to stimulate the spinal cord and block pain signals. Using patient feedback, an optimal stimulation pattern is determined and programmed into the external stimulator. The patient is sent home and asked to resume normal activities. At the end of seven days, the leads are taken out. If patient had good pain relief, then the patient is scheduled with a surgeon to place the permanent stimulator. Permanent implantation is usually done under general anesthesia. The surgeon places the leads in the epidural space, and then connects the leads to the electrical pulse generator battery under the skin. The battery is usually placed over the buttock, or abdomen.
As with any invasive procedure, there are some associated risks and complications. Anytime a needle is put into the body, there is a risk of infection, bleeding and allergic reaction. The risk of infection is prevented by using sterile techniques. The risk of bleeding is very minimal if patients are not on any blood thinners. There are very few allergic reactions to the medications that are used for the injection. If any allergic reactions are identified, medications will be given and patients will be observed to prevent any serious complications.
Epidural lead placement may also pose a risk for a spinal headache. A spinal headache is a headache that gets worse with sitting up. It usually improves in 1-2 days with lying flat, drinking water and taking caffeine. Occasionally, a persistent spinal headache must be treated with a blood patch. Patients with a persistent spinal headache should contact the office.
Patients usually go home about 20-30 minutes after the injection. Patients are educated on the use of the external spinal cord stimulator. Patients are advised to rest on the day of the injection, but may return to normal activities the next day. Patients will often be instructed to make a follow-up appointment in seven days after the trial implantation.